Compass Therapeutics Inc.
CMPX | NASDAQ
$1.33
-$0.49 (-26.92%)
Sep 22, 2026, 11:30 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 850K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 368K | 370K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -368K | -370K | n/a | n/a | n/a | n/a | n/a | 850K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -26.98M | -20.3M | -17.99M | -15.82M | -21.07M | -17.97M | -16.57M | -12.24M | -15.05M | -12.77M | -15.39M | -11.93M | -13.34M | -9.71M | -12.89M | -12.6M | -8.99M | -7.18M | -13M | -5.85M | -55.69M | -7.34M |
Interest Income | 1.83M | 1.98M | 2.27M | 1.56M | 1.19M | 1.33M | 1.59M | 1.76M | 1.97M | 1.98M | 1.98M | 1.96M | 2.06M | 1.87M | 1.29M | 623K | 424K | 20K | 4K | 1K | 9K | 15K |
Pretax Income | -25.15M | -18.32M | -15.72M | -14.26M | -19.88M | -16.63M | -15.03M | -10.48M | -13.08M | -10.79M | -13.42M | -9.96M | -11.28M | -7.84M | -11.59M | -11.98M | -8.49M | -7.16M | -12.99M | -5.98M | -55.79M | -7.42M |
Net Income | -25.15M | -18.32M | -15.72M | -14.26M | -19.88M | -16.63M | -15.03M | -10.48M | -13.08M | -10.79M | -13.42M | -9.96M | -11.28M | -7.84M | -11.59M | -11.98M | -8.49M | -7.16M | -12.98M | -5.98M | -55.8M | -7.42M |
Selling & General & Admin | 7.4M | 6.56M | 4.32M | 2.99M | 4.65M | 4.91M | 3.54M | 3.63M | 4.72M | 3.25M | 2.97M | 3.1M | 3.11M | 3.07M | 2.96M | 2.81M | 3.13M | 2.77M | 3.43M | 2.7M | 2.17M | 2.64M |
Research & Development | 19.58M | 13.38M | 13.67M | 12.83M | 16.42M | 13.05M | 13.04M | 8.61M | 11.17M | 9.52M | 12.43M | 8.83M | 10.22M | 6.64M | 9.93M | 9.79M | 5.86M | 4.42M | 9.57M | 3.15M | 2.91M | 4.7M |
Other Expenses | n/a | n/a | -370K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 50.62M | n/a |
Operating Expenses | 26.98M | 19.93M | 17.62M | 15.82M | 21.07M | 17.97M | 16.57M | 12.24M | 15.9M | 12.77M | 15.39M | 11.93M | 13.34M | 9.71M | 12.89M | 12.6M | 8.99M | 7.18M | 13M | 5.85M | 55.69M | 7.34M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.29M | 623K | 424K | 20K | 39K | 78K | 111K | 142K |
Selling & Marketing Expenses | n/a | -353K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 26.98M | 20.3M | 17.99M | 15.82M | 21.07M | 17.97M | 16.57M | 12.24M | 15.9M | 12.77M | 15.39M | 11.93M | 13.34M | 9.71M | 12.89M | 12.6M | 8.99M | 7.18M | 13M | 5.85M | 55.69M | 7.34M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -13K | n/a | 13K | n/a |
Shares Outstanding (Basic) | 186.8M | 186.4M | 184.84M | 138.28M | 138.28M | 138.24M | 136.63M | 137.59M | 137.59M | 136.61M | 127.67M | 127.42M | 126.73M | 126.38M | 105.19M | 101.01M | 100.95M | 100.86M | 51.91M | 61.69M | 51.91M | 51.31M |
Shares Outstanding (Diluted) | 186.8M | 186.4M | 184.84M | 138.28M | 138.28M | 138.24M | 136.63M | 137.59M | 137.59M | 136.61M | 127.67M | 127.42M | 126.73M | 126.38M | 105.19M | 101.01M | 100.95M | 100.86M | 51.91M | 61.69M | 51.91M | 51.31M |
EPS (Basic) | -0.13 | -0.10 | -0.09 | -0.10 | -0.14 | -0.12 | -0.11 | -0.08 | -0.10 | -0.08 | -0.11 | -0.08 | -0.09 | -0.05 | -0.10 | -0.11 | -0.08 | -0.07 | -0.25 | -0.10 | -1.07 | -0.14 |
EPS (Diluted) | -0.13 | -0.10 | -0.09 | -0.10 | -0.14 | -0.12 | -0.11 | -0.08 | -0.10 | -0.08 | -0.11 | -0.08 | -0.09 | -0.05 | -0.10 | -0.11 | -0.08 | -0.07 | -0.25 | -0.10 | -1.07 | -0.14 |
EBITDA | -25.13M | -17.95M | -15.35M | -14.24M | -19.51M | -16.27M | -14.67M | -10.02M | -12.61M | -10.32M | -13.25M | -9.5M | -10.8M | -7.36M | -11.11M | -10.87M | -7.57M | -6.71M | -12.56M | -5.49M | -55.27M | -6.87M |
EBIT | -25.15M | -18.32M | -15.72M | -14.26M | -19.88M | -16.63M | -15.03M | -10.48M | -13.08M | -10.79M | -13.42M | -9.96M | -11.28M | -7.84M | -11.59M | -11.35M | -8.07M | -7.14M | -12.96M | -5.9M | -55.68M | -7.28M |
Depreciation & Amortization | 21K | 368K | 370K | 19K | 367K | 364K | 359K | 465K | 466K | 463K | 161K | 466K | 475K | 481K | 484K | 487K | 498K | 435K | 396K | 406K | 409K | 413K |
Add to Watchlist
Select watchlists to add or remove CMPX